Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Tomotherapy Inc.
New York biotech is partnering with researchers at Columbia, Kansas State and Southern Research to address the pandemic.
Company specializing in trading upfront cash for downstream earnings makes its public debut with largest IPO of 2020, and the second largest ever in biopharma.
TNX-1600 joins two other candidates, including Phase III TNX-102 SL, in Tonix’s PTSD portfolio. CureVac and Yale partner on mRNA therapies for pulmonary disease.
Irish biotech focused on Endobody vaccine candidates partners with Boston U. in CTE and U. of Texas in Alzheimer’s. Lupus Research Alliance affiliate will help Bristol conduct a Phase II trial of Tyk2 inhibitor in lupus.
- Other Names / Subsidiaries
- Chengdu Twin Peak Accelerator Technology Inc.